from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3896c/-

LFCtreatmentdescriptionclass of inhibitor

-0.333

Amikacinug/mL Amikacintranslation

0.217

Cap5-10ug/mL Capreomycintranslation

0.278

Rox10-50 ug/mL Roxithromycintranslation

-0.286

SM2-5 ug/mL Streptomycintranslation

1.458

Tet5-10 ug/mL Tetracyclinetranslation

0.375

Rif0.2-5ug/mL Rifampicintranscription

-0.261

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.732

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.923

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.257

CPZ10-50 ug/mL Chlorpromazinerespiration

0.417

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.089

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.288

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.702

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.187

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.350

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.818

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.304

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.335

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.026

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.869

KCN5-20 ug/mL Potassium cyaniderespiration

0.684

NaN30.2-2 mM Sodium aziderespiration

0.197

Nigericin50 uM Nigericinrespiration

0.162

TRC10-150 ug/mL Triclosanrespiration

0.912

TRZ10-25 ug/mL Thioridazinerespiration

3.411

Valinomycin0.5-10 uM Valinomycinrespiration

1.038

ZnSO42 mM ZnSO4respiration

1.330

menadione6-10 ug/mL Menadionerespiration

0.448

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.323

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.237

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.176

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.722

NRP_1Non-replicating persistence stage 1dosRassociated

-0.266

Amp0.2mg/mL AmpicillincellWall

-0.216

Cephalexin20-100 ug/mL CephalexincellWall

-0.147

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.545

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.369

EMB10-20 ug/mL EthambutolcellWall

-0.694

Eta12-40 ug/mL EthionamidecellWall

-1.130

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.758

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.422

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.094

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.061

BZA0.12 mg/mL BenzamidearomaticAmides

-0.331

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.446

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.890

H2O24 mM hydrogen peroxideDNAdamaging

-0.231

Levo10 ug/mL LevofloxacinDNAdamaging

-0.566

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.588

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.289

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.982

UVUV-irradiationDNAdamaging

2.851

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.211

Antimycin12.5-50 ug/mL Antimycin A?

0.433

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.043

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.365

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.313

PA8240.2-2 ug/mL PA-824?

-0.227

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.560

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.077

Verapamil50 uM Verapamil?

0.163

mercaptoethanol2 mM 2-Mercaptoethanol?

0.820

methoxatin10-20 ug/mL Methoxatin?